Birth Defects Lawsuits

National Resource for Birth Defects Injury Victims and their families

Home

Recent study and research has continuously led to results showing a link between the use of Selective Serotonin Reuptake Inhibitors (SSRI’s) during pregnancy and a higher risk of birth defects in children. The risk of birth defects includes a major issue in persistent pulmonary hypertension of the newborn, also referred to as PPHN. Serotonin reuptake inhibitors are also being linked to numerous other lung and heart defects in children when used during pregnancy.

Research

Multiple reports and research studies, such as one published in the New England Journal of Medicine, have linked a group of these inhibitors to serious birth defects. Women who use SSRI’s have been found with an increased likelihood of birth defects by nearly six times, when compared to those who don’t take them.  

FDA Warnings

Since 2006, the FDA has continued to issue warnings focusing on the link between SSRI’s and birth defects when used during pregnancy. Primarily focusing on persistent pulmonary hypertension, the FDA has issued continuous notices to doctors advising them to weigh the benefits and risks of treating pregnant women with SSRI’s. The original FDA warning in 2006 also mentioned birth defects risk being six times higher in women taking SSRI's during pregnancy. 

What We Can Do

Here at Birth Defects Lawsuits we have a comprehensive database of information focusing on a number of these Selective Serotonin Reuptake Inhibitors. This website is dedicated to keeping the public informed about the side effects, birth defects and legal issues which surround these drugs and their links to common birth defects.

Some of the SSRI’s that have been linked to common birth defects include:

Depakote

Lexapro

Paxil

Prozac

Topamax

Zoloft

Free Case Review

Free Case Review

How can we reach you?